Skip to main content

Triumph Capital Management

Position in GILD — Gilead Sciences, Inc.

CIK 1730765 DENVER, CO

Position in GILD

as of Jun 30, 2026 · filed Jul 21, 2026
Position Value
$465,815
-$36,892 QoQ
Shares Held
3,687
+2.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,403
of 2,265 holders
Holding Since
Mar 2022
15 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Triumph Capital Management holds $8,936,522 across 15 Drug Manufacturers - General names. GILD ranks #6 (5.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 GILD
Gilead Sciences, Inc.
This page
3,687 $465,815

All Filings in GILD

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $465,815 3,687
2026-03-31 $502,707 3,607
2025-12-31 $411,424 3,352
2025-09-30 $367,854 3,314
2025-06-30 $315,314 2,844
2025-03-31 $323,824 2,890
2024-12-31 $283,575 3,070
2024-09-30 $264,431 3,154
2024-06-30 $1,385,853 20,199
2024-03-31 $580,726 7,928
2023-03-31 $203,691 2,455
2022-12-31 $211,019 2,458
2022-09-30 $567,733 9,203
2022-06-30 $535,089 8,657
2022-03-31 $511,805 8,609